Morrow, Gary R
- University of Rochester · Surgery (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #539
- Sustained Excellence
- Top 5% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Surgery
NIH Funding · FY2023
Linked Award Amount
$6.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#539
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Morrow, Gary R as a PI. Multi-PI records show the full award amount for context.
- 5UG1CA189961-10UG1Contact PIURCC NCORP Research BaseUniversity of Rochester · Surgery (NIH department code)$6Maward amount
- 3UG1CA189961-10S1UG1Contact PISexual Orientation and Gender Identity Data Collection in Community Oncology PracticeUniversity of Rochester · Surgery (NIH department code)$100Kaward amount
Award organization
Organizations that administered FY2023 awards listing Morrow, Gary R as a PI.
FY2023 award administered by University of Rochester (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of Rochester
- 2001$500K Cumulative Funding
- 2001Entered Top 50% NationallyRanked #3635
- 2001Entered Top 25% NationallyRanked #3635
- 2002$1M Cumulative Funding
- 2003$2M Cumulative Funding
- 2005$5M Cumulative Funding
- 2021$10M Cumulative Funding
- 2021Entered Top 10% NationallyRanked #548
- 2021Entered Top 5% NationallyRanked #548